INITIATIVE ON GINKGO BILOBA

Release Date:  January 29, 1999

P.T.

National Center for Complementary and Alternative Medicine

The National Center for Complementary and Alternative Medicine (NCCAM), and
several NIH Institutes are developing a Request for Applications (RFA) to
initiate a high-quality, double-blind, randomized, placebo-controlled
multi-site prevention trial of the botanical product, ginkgo biloba, in the
older, ambulatory individual.  The funding mechanism will be a cooperative
agreement (U01).  It is anticipated that one award will be made at a maximum
total cost of $15 million spread over five years.

The anticipated release date for the RFA is in mid-February 1999, with
applications being due on May 21, 1999.  The announcement will be published in
the NIH Guide for Grants and Contracts in the usual manner. 
INQUIRIES

General inquiries in regarding this notice may be directed to:

Richard L. Nahin, Ph.D., M.P.H.
National Center for Complementary and Alternative Medicine
9000 Rockville Pike, Room 5B-38
Bethesda, MD  20892-2182
Telephone:  (301) 496-4792
FAX:  (301) 594-6757
Email:  [email protected]

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)